XML 115 R99.htm IDEA: XBRL DOCUMENT v3.22.4
Compensation and Benefit Plans (Option Activity) (Details) - Stock options
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Stock Options  
Beginning balance (in shares) | shares 12,354,826
Grants (in shares) | shares 909,504
Forfeited or expired (in shares) | shares (223,836)
Exercised (in shares) | shares (1,156,938)
Ending balance (in shares) | shares 11,883,556
Vested and expected to vest (in shares) | shares 11,538,210
Exercisable (in shares) | shares 8,074,165
Weighted Average Grant Date Fair Value  
Beginning balance, weighted average exercise price (in dollars per share) | $ / shares $ 62.78
Granted, weighted average exercise price (in dollars per share) | $ / shares 63.67
Forfeited or expired, weighted average exercise price (in dollars per share) | $ / shares 64.89
Exercised, weighted average exercise price (in dollars per share) | $ / shares 54.16
Ending balance, weighted average exercise price (in dollars per share) | $ / shares 63.64
Vested and expected to vest, weighted average exercise price (in dollars per share) | $ / shares 63.73
Exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 64.94
Remaining Contractual Term (Years)  
Outstanding at December 31, 2016 (term) 5 years 5 months 4 days
Vested and expected to vest at December 31, 2016 (term) 5 years 4 months 6 days
Exercisable at December 31, 2016 (term) 4 years 3 months 21 days
Aggregate Intrinsic Value (in millions)  
Vested and expected to vest at December 31, 2019 | $ $ 30
Exercisable at December 31, 2019 | $ 17
Exercise of option, tax benefit | $ $ 5
SCE  
Stock Options  
Beginning balance (in shares) | shares 6,180,154
Grants (in shares) | shares 470,852
Forfeited or expired (in shares) | shares (143,235)
Exercised (in shares) | shares (810,294)
Transfers, net (in shares) | shares 100,155
Ending balance (in shares) | shares 5,797,632
Vested and expected to vest (in shares) | shares 5,620,440
Exercisable (in shares) | shares 3,849,057
Weighted Average Grant Date Fair Value  
Beginning balance, weighted average exercise price (in dollars per share) | $ / shares $ 62.03
Granted, weighted average exercise price (in dollars per share) | $ / shares 63.51
Forfeited or expired, weighted average exercise price (in dollars per share) | $ / shares 64.83
Exercised, weighted average exercise price (in dollars per share) | $ / shares 53.78
Affiliate transfers, net, weighted average grant date fair value (in dollars per share) | $ / shares 66.09
Ending balance, weighted average exercise price (in dollars per share) | $ / shares 63.31
Vested and expected to vest, weighted average exercise price (in dollars per share) | $ / shares 63.40
Exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 64.64
Remaining Contractual Term (Years)  
Outstanding at December 31, 2016 (term) 5 years 5 months 12 days
Vested and expected to vest at December 31, 2016 (term) 5 years 4 months 17 days
Exercisable at December 31, 2016 (term) 4 years 3 months 10 days
Aggregate Intrinsic Value (in millions)  
Vested and expected to vest at December 31, 2019 | $ $ 17
Exercisable at December 31, 2019 | $ 9
Exercise of option, tax benefit | $ $ 3